Skip to main content
Clinical Trials/NCT05672784
NCT05672784RecruitingNot Applicable

Genicular Nerve Block Versus Its Combination With Infiltration Between Popliteal Artery and Capsule of Posterior Knee for Enhanced Recovery After Total Knee Arthroplasty

Zagazig University1 site in 1 country63 target enrollmentStarted: November 5, 2022Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
63
Locations
1
Primary Endpoint
2 hours visual analogue scale

Study Overview

Brief Summary

Comparison of the analgesic and physical recovery effect of genicular nerve block (GNB) alone and (GNB + infiltration between popliteal artery and posterior capsule of the knee (IPACK) in patients undergoing total knee replacement

Detailed Description

Comparison of preemptive analgesia of (GNB) with (GNB+ IPACK) on postoperative pain control and recovery of knee physical activity in patient undergoing total knee replacement.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
21 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

C group

Active Comparator

the patients will take standard analgesia ( meloxicam (15 mg) once a day + paracetamol 1gm /3 times a day). ,with no nerve block

Intervention: standard analgesia (paracetamol and meloxicam) (Drug)

G group

Active Comparator

the patients will take standard analgesia plus GNB

Intervention: GNB plus standard analgesia (Procedure)

G group

Active Comparator

the patients will take standard analgesia plus GNB

Intervention: standard analgesia (paracetamol and meloxicam) (Drug)

GI group

Active Comparator

the patients will take standard analgesia plus GNB plus IPACK

Intervention: GNB plus IPACK block plus standard analgesia (Procedure)

GI group

Active Comparator

the patients will take standard analgesia plus GNB plus IPACK

Intervention: standard analgesia (paracetamol and meloxicam) (Drug)

Outcomes

Primary Outcomes

2 hours visual analogue scale

Time Frame: at 2 hour postoperative.

pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".

4 hours visual analogue score

Time Frame: at 4 hours postoperative

pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".

8 hours visual analogue score

Time Frame: at 8 hours postopertaive

pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".

18 hours visual analogue score

Time Frame: at 18 hours postoperative

pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".

24 hours visual analogue score

Time Frame: at 24 hours postoperative

pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".

6 hours visual analogue score

Time Frame: at 6 hours postoperative

pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".

12 hours visual analogue score

Time Frame: at 12 hours postoperative

pain intensity at rest and with motion using visual analogue scale from " horizontal line of 10-cm long with two ends, one end indicate no pain 0 and the other end indicate worst pain 10".

Secondary Outcomes

  • • Total morphine consumption(at 24 hours post-operatively)
  • degree of maximum active flexion and extension of the knee(at 24 hours post operative)
  • walk test(at 24 hours post operative)
  • holding quadriceps muscle(at 24 hours post operative)
  • • Time of performance of block(from putting of U.S probe till the end of block procedure)
  • •incidence of Anticipated side effect(at 24,48 hours postoperative)
  • time up and go (TUG)(at 24 hours post operative)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Heba M Fathi

Dr. Heba M Fathi

Zagazig University

Study Sites (1)

Loading locations...

Similar Trials